Neurodivergent Center of America, LLC – Trademark Portfolio
Entity Type: 16
Neurodivergent Center of America, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include ETEP, PLAY N GROW, LET’S PLAY N GROW, NEURODIVERGENT CENTER OF AMERICA, and EARLY TALENT EXPLORATION PROGRAM (ETEP). The owner is based in Dallas, TX.
6060 N Central Expressway, Unit 500
Dallas, TX 75206
Showing of trademarks Trademarks
Trademark Classifications
Neurodivergent Center of America, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Neurodivergent Center of America, LLC have?
Neurodivergent Center of America, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Neurodivergent Center of America, LLC file in?
Neurodivergent Center of America, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Neurodivergent Center of America, LLC's most well-known trademarks?
Neurodivergent Center of America, LLC's registered trademark portfolio includes well-known marks such as ETEP, PLAY N GROW, LET’S PLAY N GROW, NEURODIVERGENT CENTER OF AMERICA, and EARLY TALENT EXPLORATION PROGRAM (ETEP). These are among 5 currently registered trademarks in the portfolio.
What is Neurodivergent Center of America, LLC's trademark registration success rate?
Neurodivergent Center of America, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.